Cyclerion Therapeutics (CYCN) Other Non-Current Assets (2018 - 2023)
Cyclerion Therapeutics (CYCN) posted quarterly Other Non-Current Assets of $1.9 million for Q2 2023, down 16.41% year-over-year from $2.2 million in Q2 2022, and down 4.67% quarter-over-quarter from $2.0 million in Q1 2023.
Cyclerion Therapeutics (CYCN) Other Non-Current Assets (2018 - 2023) Analysis & Trends
Cyclerion Therapeutics' Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $1.9 million for Q2 2023.
- In Q2 2023, Other Non-Current Assets fell 16.41% year-over-year to $1.9 million; the TTM figure through Jun 2023 stood at $1.9 million (down 16.41% YoY), while the FY2022 annual figure was $2.0 million, down 15.21% from the prior year.
- Other Non-Current Assets for Q2 2023 stood at $1.9 million, down from $2.0 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $5.0 million in Q2 2020, with the low at $19000.0 in Q1 2019.
- The 5-year median for Other Non-Current Assets is $2.2 million (2022), against an average of $2.2 million.
- The sharpest annual moves came in 2020 and 2021: Other Non-Current Assets jumped 5473.68% in 2020, then sank 48.11% in 2021.
- Cyclerion Therapeutics' Other Non-Current Assets stood at $540000.0 in 2019, then surged by 610.56% to $3.8 million in 2020, then slumped by 37.27% to $2.4 million in 2021, then fell by 15.21% to $2.0 million in 2022, then retreated by 8.92% to $1.9 million in 2023.
- Business Quant data shows CYCN's Other Non-Current Assets at $1.9 million in Q2 2023, $2.0 million in Q1 2023, and $2.0 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | Cyclerion Therapeutics | 12.71 Mn | 9.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.86 Mn |
| Mar 31, 2023 | 1.95 Mn |
| Dec 31, 2022 | 2.04 Mn |
| Sep 30, 2022 | 2.13 Mn |
| Jun 30, 2022 | 2.22 Mn |
| Mar 31, 2022 | 2.32 Mn |
| Dec 31, 2021 | 2.41 Mn |
| Jun 30, 2021 | 2.59 Mn |
| Mar 31, 2021 | 2.68 Mn |
| Dec 31, 2020 | 3.84 Mn |
| Sep 30, 2020 | 2.80 Mn |
| Jun 30, 2020 | 4.99 Mn |
| Mar 31, 2020 | 1.06 Mn |
| Dec 31, 2019 | 540,000.00 |
| Mar 31, 2019 | 19,000.00 |
| Dec 31, 2018 | 25,000.00 |